Neurogene Inc.: Form 8-K, filed Nov 12, 2024
Filed with the SEC on Nov 12, 2024 and accepted by EDGAR at Nov 12, 2024, 06:05 ET.
Items reported
- Item 7.01 Regulation FD disclosure
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001404644-24-000091. Last ingested by Listed: Nov 10, 2026, 01:44 ET. Listed shows no prices and gives no investment advice.